Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

NSCLC 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Carboplatin 7 Pemetrexed 6 osimertinib 5 Drug Therapy 5 aflutinib 4 tislelizumab 3 anlotinib 3 Radiotherapy 3 Radiosurgery 3 Paclitaxel 3 Cisplatin 3 toripalimab 2 pembrolizumab 2 camrelizumab 2 apatinib 2 Surgical Procedures, Operative 2 S 1 (combination) 2 HM781-36B 2 Chemotherapy, Adjuvant 2 Chemoradiotherapy 2 trilaciclib 1 surufatinib 1 sintilimab 1 rezivertinib 1 lenvatinib 1 icotinib 1 famitinib 1 envafolimab 1 dacomitinib 1 cemiplimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × NSCLC × JDQ443 × Clear all

NCT05714891 2026-02-12

Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer

Canadian Cancer Trials Group

Phase 2 Active not recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡